The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Randomized, double-blind, placebo-controlled phase 3 study of ibrutinib plus rituximab in patients with previously untreated marginal zone lymphoma (MZL).

Ariela  Noy

Consulting or Advisory Role - Janssen Biotech; MorphoSys; Prime Oncology

Research Funding - Pharmacyclics; Rafael Pharmaceuticals

Travel, Accommodations, Expenses - Janssen Oncology; Pharmacyclics

Stephanie  Hughes

Employment - Merck

Erin  Biggar

No Relationships to Disclose

Matthew  Bogdan

No Relationships to Disclose